1. Cost-effectiveness landscape analysis of treatments addressing xerostomia in patients receiving head and neck radiation therapy
- Author
-
Andrew T. Hosford, Maria Anne Sodini, Todd J. Brinton, Davud Sirjani, Edward E. Graves, Joëlle K. Barral, Dale J. Waters, Paul G. Yock, Elizabeth A. Zambricki, Quynh-Thu Le, and Laura S. Sasportas
- Subjects
medicine.medical_specialty ,Cost effectiveness ,Cost-Benefit Analysis ,medicine.medical_treatment ,Salivary Gland Diseases ,Xerostomia ,Article ,Salivary Glands ,Pathology and Forensic Medicine ,stomatognathic system ,Quality of life ,Internal medicine ,medicine ,Humans ,Radiology, Nuclear Medicine and imaging ,Dentistry (miscellaneous) ,In patient ,Head and neck ,Radiotherapy ,business.industry ,Cancer ,Dry mouth ,medicine.disease ,Surgery ,Radiation therapy ,Head and Neck Neoplasms ,Quality of Life ,Oral Surgery ,medicine.symptom ,business - Abstract
Head and neck (H&N) radiation therapy (RT) can induce irreversible damage to the salivary glands thereby causing long-term xerostomia or dry mouth in 68%–85% of the patients. Not only does xerostomia significantly impair patients’ quality-of-life (QOL) but it also has important medical sequelae, incurring high medical and dental costs. In this article, we review various measures to assess xerostomia and evaluate current and emerging solutions to address this condition in H&N cancer patients. These solutions typically seek to accomplish 1 of the 4 objectives: (1) to protect the salivary glands during RT, (2) to stimulate the remaining gland function, (3) to treat the symptoms of xerostomia, or (4) to regenerate the salivary glands. For each treatment, we assess its mechanisms of action, efficacy, safety, clinical utilization, and cost. We conclude that intensity-modulated radiation therapy is both the most widely used prevention approach and the most cost-effective existing solution and we highlight novel and promising techniques on the cost-effectiveness landscape.
- Published
- 2013
- Full Text
- View/download PDF